A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes

Ping Zhao (1) , Meng-Meng Ji (1) , Ying Fang (1) , Xiao Li (1) , Hong-Mei Yi (1) , Zi-Xun Yan (1) , Shu Cheng (1) , Peng-Peng Xu (1) , Anne Janin (2, 3) , Chao-Fu Wang (1) , Li Wang (1) , Wei-Li Zhao (1)

1 Shanghai Jiao Tong University School of Medicine
2 AP-HP - Hopital Saint-Louis [AP-HP]
3 UFR Médecine UPCité - UFR Médecine [Santé] - Université Paris Cité

Abstract Long noncoding RNAs (lncRNAs) play an essential role in tumor progression. Few researches focused on the clinical and biological relevance of lncRNAs in peripheral T cell lymphoma (PTCL). In this research, a novel lncRNA (ENST00000503502) was identified overexpressed in the main subtypes of PTCL, and designated as T cell lymphoma-associated lncRNA1 (TCLlnc1). Serum TCLlnc1 was associated with extranodal involvement, high-risk International Prognostic Index, and poor prognosis of the patients. Both in vitro and in vivo, overexpression of TCLlnc1 promoted T-lymphoma cell proliferation and migration, both of which were counteracted by the knockdown of TCLlnc1 using small interfering RNAs. As the mechanism of action, TCLlnc1 directly interacted with transcription activator heterogeneous nuclear ribonucleoprotein D (HNRNPD) and Y-box binding protein-1 (YBX1) by acting as a modular scaffold. TCLlnc1/HNRNPD/YBX1 complex upregulated transcription of TGFB2 and TGFBR1 genes, activated the tumor growth factor-β signaling pathway, resulting in lymphoma progression, and might be a potential target in PTCL.

Domaines: Sciences du Vivant [q-bio]

Ping Zhao, Meng-Meng Ji, Ying Fang, Xiao Li, Hong-Mei Yi, et al.. A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes. Cell Death and Disease, 2021, 12 (4), ⟨10.1038/s41419-021-03594-y⟩. ⟨hal-03258381⟩